US biopharma AbbVie has signed a global collaboration agreement with China’s I-Mab to develop and commercialize lemzoparlimab – also known as TJC4 – an anti-CD47...
17.06.2020
- US drugmaker AbbVie has signed two separate collaboration agreements, one with Denmark’s Genmab and the other with China’s Jacobio Pharmaceuticals, for developing and...
17.01.2020
- Japanese drugmaker Takeda is facing a large tax bill from Ireland as an uncalculated repercussion of its acquisition of US-managed, Ireland-domiciled Shire at the end of 2018. Tax...
04.10.2019
- The US Federal Trade Commission (FTC) has requested additional information from both Allergan and AbbVie as it digs deeper into the proposed merger of the two drugmakers. Biopharma...
13.09.2019
- Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...
27.06.2019
- In a deal expected to close early next year, US biopharma AbbVie is buying troubled Botox manufacturer Allergan for $63 billion in cash and shares. The acquisition is the second...
05.04.2019
- Frankfurt / Weinheim, 03 April 2019. Seven companies from the chemical and pharmaceutical industries have been awarded the "Best Employer in Chemistry" prize as part of the new...
14.02.2019
- US biopharma AbbVie has agreed a deal with Teneobio, a California-based biotech, to develop and commercialize an immunotherapeutic that targets B-cell maturation antigen (BCMA) for...